Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stem Cells

NCT04361942 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Pneumonia

Interventions

BIOLOGICAL: Mesenchymal Stem Cells (MSCs)
OTHER: Placebo

Sponsor

Red de Terapia Celular

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]